12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

Antitope, Research Corporation Technologies Inc. deal

The companies partnered to re-engineer a toxic protein "warhead" from Research Corporation for use in antibody-drug conjugates (ADCs) against a range of...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >